Glaukos
+$0.29 (+0.62%) As of 2:28 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.
About GKOS
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.
CEO
Thomas William Burns
Employees
653
Headquarters
San Clemente, California
Founded
1998
GKOS Key Statistics
Market Cap
2.17B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
756.03K
High Today
$46.70
Low Today
$46.16
Open Price
$46.16
Volume
16.58K
52 Week High
$99.00
52 Week Low
$43.71
Analyst Ratings
67%
of 12 ratings
Buy
8.3%
Hold
66.7%
Sell
25%
GKOS Earnings
-$0.76
-$0.51
-$0.25
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Available Nov 4, After Hours